Records containing: Neurofibromatosis 1
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2021-08-05Mechanism of Action of Transcranial Direct Current Stimulation in Neurofibromatosis Type 1
-
CLINICAL_TRIALS study record update · 2021-04-27Effectiveness of a Telehealth Group for Improving Peer Relationships for Adolescents With Neurofibromatosis Type 1
-
CLINICAL_TRIALS study record update · 2021-04-26Effectiveness of a Telehealth Group for Improving Peer Relationships for Adolescents With Neurofibromatosis Type 1
-
CLINICAL_TRIALS study record update · 2021-04-02Linking Inhibition From Molecular to Systems and Cognitive Levels: a Preclinical and Clinical Approach in Autism Spectrum Disorders and Neurofibromatosis.
-
CLINICAL_TRIALS study record update · 2021-03-02Whole Body MRI to Identify Atypical Neurofibromas in Patients With NF1 and High Plexiform Neurofibroma Tumor Burden
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2020-11-25Comparison of Gastrointestinal Motility in Healthy Children and Children With Constipation
-
CLINICAL_TRIALS study record update · 2019-11-01Genetic Evaluation for the Scoliosis Gene(s) in Patients With Neurofibromatosis 1 and Scoliosis
-
CLINICAL_TRIALS study record update · 2019-04-24Use of Non-invasive Brain Stimulation for Working Memory Deficits in Neurofibromatosis Type 1
-
CLINICAL_TRIALS study record update · 2019-04-05A Phase II Trial of the Mitogen Activated Protein Kinase Kinase (MEK1/2) Inhibitor Selumetinib (AZD6244 Hydrogen Sulfate) in Patients With Neurofibromatosis Type 1 (NF1) Mutated Gastrointestinal Stromal Tumors (GIST)
-
CLINICAL_TRIALS study record update · 2019-01-31Effects of an Internet Support Group for Parents of a Child With Neurofibromatosis Type 1
-
CLINICAL_TRIALS study record update · 2017-10-26Clinical Assessment of the Use of Topical Liquid Diclofenac Following Laser Microporation of Cutaneous Neurofibromas in Patients With Neurofibromatosis Type 1
-
CLINICAL_TRIALS study record update · 2017-10-02ClinicalTrials.gov study NCT03298438
-
CLINICAL_TRIALS study record update · 2017-06-06Everolimus for Treatment of Disfiguring Cutaneous Lesions in Neurofibromatosis1- CRAD001CUS232T
-
CLINICAL_TRIALS study record update · 2016-11-22Trial to Evaluate the Safety of Lovastatin in Individuals With Neurofibromatosis Type I (NF1)
-
CLINICAL_TRIALS study record update · 2016-02-11Analysis of Plasma for Diagnosis and Follow-up of Neurofibromatosis Type 1
-
CLINICAL_TRIALS study record update · 2014-06-16Study of the Neurofibromatosis 1 Expression: Identification of the Modifying Genes
-
CLINICAL_TRIALS study record update · 2013-01-28Whole Body Magnetic Resonance Imaging With Diffusion Weighted Imaging : Potential Role in Neurofibromatosis
-
CLINICAL_TRIALS study record update · 2012-07-12Phase II Trial of Pirfenidone in Children, Adolescents, and Young Adults With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas